InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,162.00
(
-0.07%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,895.65
(
-1.48%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Monday, 04/11/2011 8:50:43 AM

Monday, April 11, 2011 8:50:43 AM

Post# of 92948
EU Orphan designation would appear to fall into one of the following categories as it was not approved at last meeting.


Monthly report
Committee for Orphan Medicinal Products (COMP)
6-7 April 2011

Lists of questions
The COMP adopted 3 lists of questions on initial applications. These applications will be discussed again at the next COMP meeting prior to adoption of the opinion.
Oral hearings
Two oral hearings took place.
Withdrawals of applications for orphan medicinal product designation
The COMP noted that 1 application for orphan medicinal product designation was withdrawn.
Upcoming meetings
The 123rd meeting of the COMP will be held on 4-5 May 2011.
http://www.ema.europa.eu/docs/en_GB/document_library/Committee_meeting_report/2011/04/WC500105111.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up